ijms-logo

Journal Browser

Journal Browser

Allosteric Regulation of the Hormone and Growth Factor Receptors

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Immunology".

Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 2363

Special Issue Editors


E-Mail Website
Guest Editor
Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223 St. Petersburg, Russia
Interests: signal transduction; allosteric site; allosteric regulator; positive allosteric modulator; negative allosteric modulator; hormone; growth factor; cytokine; heterotrimeric G-protein; adenylyl cyclase; G-protein-coupled receptor; tyrosine kinase receptor; cytokine receptor; receptor complex; insulin; leptin; interleukin; epidermal growth factor; central nervous system; endocrine system; neurodegeneration
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Sechenov Institute of Evolutionary Physiology and Biochemistry, Russian Academy of Sciences, 194223 St. Petersburg, Russia
Interests: signal transduction; allosteric site; allosteric regulator; positive allosteric modulator; negative allosteric modulator; hormone; growth factor; cytokine; heterotrimeric G-protein; adenylyl cyclase; G-protein-coupled receptor; tyrosine kinase receptor; cytokine receptor; receptor complex; insulin; leptin; interleukin; epidermal growth factor; central nervous system; endocrine system; neurodegeneration

Special Issue Information

Dear Colleagues,

Hormones, growth factors, cytokines, and other signaling molecules, by specifically binding to the orthosteric (high-affinity) site of G protein-coupled receptors (GPCRs), tyrosine kinases receptors and cytokine receptors, cause their activation and mediate the transmission of an external signal to intracellular signaling cascades. As a result, an adequate cellular response to hormonal stimuli is ensured. At the same time, the regulation of the activity of these receptors can be carried out by interacting with allosteric regulators, which specifically, but with a lower affinity, interact with allosteric sites localized in the extracellular, intracellular, and transmembrane domains of the receptors. These sites are targets for compounds with the activity of the positive (PAM), negative (NAM) and silent (SAM) allosteric modulators, as well as for compounds with the activity of the full and inverse allosteric agonists. At present, a large number of endogenous allosteric regulators and modulators have been identified, including metal cations, lipids, steroid hormones, amino acids, peptides, proteins, etc. The most important role in the etiology and pathogenesis of autoimmune diseases belongs to specific antibodies that specifically interact with receptor allosteric sites. In recent years, an intensive search and study of new allosteric regulators have been carried out, which is due to significant progress in establishing the structural and functional organization of receptor allosteric sites. They have a number of significant advantages over orthosteric site ligands (high specificity for closely related receptors, bias agonism, moderate activation or inhibition of the receptor), and are also able to modulate the regulatory effects of orthosteric agonists and influence the stability of homo- and heterooligomeric receptor complexes.

A Special Issue of the International Journal of Molecular Sciences is devoted to the prospects and unresolved problems of allosteric regulation of receptors, and the main topics will be: (1) search, design and development of allosteric regulators of GPCRs, tyrosine kinases receptors and cytokine receptors, (2) molecular mechanisms of action of the endogenous and artificial allosteric regulators, (3) structure and functions of receptor allosteric sites, (4) the allosteric control of receptor oligomerization; (5) allosteric regulators/modulators-based drugs; (6) effects of allosteric regulators on cellular processes, (7) impaired allosteric regulation and diseases. The content of Special Issue is not limited to these topics. 

Authors are invited to submit original and review articles for publication in this Special Issue of IJMS.

Prof. Dr. Alexander Shpakov
Dr. Kira V. Derkach
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • signal transduction
  • allosteric site
  • allosteric regulator
  • positive allosteric modulator
  • negative allosteric modulator
  • hormone
  • growth factor
  • cytokine
  • heterotrimeric G-protein
  • adenylyl cyclase
  • G-protein-coupled receptor
  • tyrosine kinase receptor
  • cytokine receptor
  • receptor complex
  • insulin
  • leptin
  • interleukin
  • epidermal growth factor
  • central nervous system
  • endocrine system
  • neurodegeneration

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

19 pages, 6260 KiB  
Article
The Novel Small Molecule BTB Inhibits Pro-Fibrotic Fibroblast Behavior though Inhibition of RhoA Activity
by Ashley R. Rackow, David J. Nagel, Gregory Zapas, Ryan S. Clough, Patricia J. Sime and R. Matthew Kottmann
Int. J. Mol. Sci. 2022, 23(19), 11946; https://doi.org/10.3390/ijms231911946 - 8 Oct 2022
Cited by 3 | Viewed by 2076
Abstract
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic, interstitial lung disease with a poor prognosis. Although specific anti-fibrotic medications are now available, the median survival time following diagnosis remains very low, and new therapies are urgently needed. To uncover novel therapeutic targets, we [...] Read more.
Idiopathic pulmonary fibrosis (IPF) is a progressive, chronic, interstitial lung disease with a poor prognosis. Although specific anti-fibrotic medications are now available, the median survival time following diagnosis remains very low, and new therapies are urgently needed. To uncover novel therapeutic targets, we examined how biochemical properties of the fibrotic lung are different from the healthy lung. Previous work identified lactate as a metabolite that is upregulated in IPF lung tissue. Importantly, inhibition of the enzyme responsible for lactate production prevents fibrosis in vivo. Further studies revealed that fibrotic lesions of the lung experience a significant decline in tissue pH, likely due to the overproduction of lactate. It is not entirely clear how cells in the lung respond to changes in extracellular pH, but a family of proton sensing G-protein coupled receptors has been shown to be activated by reductions in extracellular pH. This work examines the expression profiles of proton sensing GPCRs in non-fibrotic and IPF-derived primary human lung fibroblasts. We identify TDAG8 as a proton sensing GPCR that is upregulated in IPF fibroblasts and that knockdown of TDAG8 dampens myofibroblast differentiation. To our surprise, BTB, a proposed positive allosteric modulator of TDAG8, inhibits myofibroblast differentiation. Our data suggest that BTB does not require TDAG8 to inhibit myofibroblast differentiation, but rather inhibits myofibroblast differentiation through suppression of RhoA mediated signaling. Our work highlights the therapeutic potential of BTB as an anti-fibrotic treatment and expands upon the importance of RhoA-mediated signaling pathways in the context of myofibroblast differentiation. Furthermore, this works also suggests that TDAG8 inhibition may have therapeutic relevance in the treatment of IPF. Full article
(This article belongs to the Special Issue Allosteric Regulation of the Hormone and Growth Factor Receptors)
Show Figures

Figure 1

Back to TopTop